Drugs-Forum  
Home Wiki Studies Forum Groups Blog Video Images News Chat
Go Back   Drugs Forum > Wiki Articles > Drug Articles
Mark Forums Read
Register Tags

Notices

Drug Articles Articles about drugs

25B-NBOMe


[top]Introduction to 25B-NBOMe



[top]Introdution

25B-NBOMe is derived from the psychedelic phenethylamine 2C-B (4-bromo-2,5-dimethoxylphenethylamine) by substitution on the amine with a 2-methoxybenzyl (BOMe) group.

The drug is a very potent partial agonist of the 5HT-2A receptor (which belongs to the serotonin group of receptors) giving it its psychedelic effects.

[top]Ways of Administration


Insufflated

(dissolved in water):
Light - 50-200 g (0.05 - 0.2 mg)
Mild - 200-350 g (0.2 - 0.35 mg)
Strong - 350-800 g (0.35 - 0.8 mg)
Very strong - 800 g -1400 g (0.8 - 1.4mg)
Insanity - 1400 g+ (1.4 mg+)

Orally

Plugged

Sublingual

IM/IV

[top]Effects of 25B-NBOMe

Sublingual

Threshold - 100ug
Mild- 100-300
Strong - 350-700
Very strong - 700ug+

Duration:8-10hours
Come Up 1hour+
Plateau 3-4hours

(More information needed to verify dosage)

From liquid insufflation (strong dose):


Extreme patterning
Masses of vibrant coloring
Strong sound distortion - sounds leaking in and out of rooms and into the user
Very strong electric spasmodic body high

Complete ego loss
Loss of self
Loss of location, being, time, space etc

Inability to function at all normally
Slight nausea but passes quickly

[top]Combinations with 25B-NBOMe

Beyond Anecdotal reports there exists no data on the combination of this drug with other agents.

Since 25B-NBOMe is a Research Chemical and very little is known about it, it is highly advised that combinations are not attempted with this substance.

[top]Different Uses for 25B-NBOMe



[top]Pharmacology of 25B-NBOMe

25B-NBOMe is a potent and selective partial agonist at the 5-HT2A receptor. [1]


[top]Chemistry of 25B-NBOMe

The following image displays the structural relationship between 2C-B, 2-methoxytoluene, and 25B-NBOMe.



[top]The Dangers of 25B-NBOMe


This is a very potent drug, the effects can peak rapidly and become uncomfortable and/or overpowering. A psychedelic crisis can occur.

These are the dangers common to all psychedelic drugs:

Accidental injury.
When on a psychedelic drug, it is easier to accidentally injure yourself. Also because of the disorientating and potentially delusion inspiring nature of the experience, you could be lead to inflict harm on others or yourself. People have fallen off rooftops, run into traffic, attempted to throw people off rooftops as 'sacrifices', drowned, and so on. The best way of protecting against this is to have a friend with you who is sober to look after you and handle any negative situation that might arise.

Bad trips. A bad trip is a negative psychedelic experience. It can range from a mildly negative feeling of anxiety/discomfort, to full-blown psychosis. Bad trips usually ruin a psychedelic experience for the tripper and everyone else. Most bad trips are manageable, just very uncomfortable and difficult. Some are extreme and unmanageable though. It's not uncommon for a bad trip to result in lingering psychological issues. Usually just a few days of negative emotions and anxiety. Sometimes, however, a week or so of serious anxiety, destabilized mental state and impaired functioning is possible. On very rare occasions, a month or two of severely diminished functioning, traumatized mental state, depression & crippling anxiety can occur. More information on bad trips can be found here. The best way of avoiding a bad trip is having the correct set and setting.

Permanent psychosis. Psychedelics are believed by researchers not to cause permanent psychosis, however they could trigger a latent mental illness in someone who was already predisposed to it, or make existing mental illnesses worse. If there is a history of mental illness in your family, you are more likely to be predisposed. Everyone is at some risk, however.

PTSD, anxiety disorder, depression & depersonalization. There are anecdotal reports of the trauma inflicted by some bad trips leading to depression and anxiety which while usually temporary, could potentially develop into lasting disorders. While no different to the potential of any traumatic event to cause lasting disorders, nonetheless this is a danger of psychedelic drug use.


[top]Producing 25B-NBOMe



[top]Forms of 25B-NBOMe

Powder
tabs - Usually 300-350ug
liquid in LSD style dropped bottles


[top]Legal Status of 25B-NBOMe

[top]United Nations

Uncontrolled

[top]USA

Uncontrolled at Federal and State level, though arguably may contravene the Federal Analog Act under certain circumstances given its structural and functional similarity to controlled substance 2C-B.

[top]EU

Legal

[top]United Kingdom

25B-NBOMe is uncontrolled in the United Kingdom, as N-benzyl derivatives of phenethylamine are not covered by the phenethylamine derivatives clause of the Misuse of Drugs Act 1971.

[top]Other Countries



[top]History of 25B-NBOMe


25B-NBOMe was first synthesized by Ralf Heim. [2]


[top]More 25B-NBOMe sections


[top]The Latest 25B-NBOMe Threads

  Article / Page Starter Last Post Comments Views
ThirdEyeFloond
23-04-2016 15:05
by zerozerohero Go to last post
4 11,896
neuxswalker
20-04-2016 00:42
by a12mcmullin Go to last post
1 4,549
firewall
16-04-2016 17:23
by zerozerohero Go to last post
36 19,876
Zehred
06-04-2016 01:40
by Zehred Go to last post
1 497
mickeyd23
05-04-2016 17:13
by Zehred Go to last post
1 625
sh4mw0w
04-04-2016 20:57
by Dabbing Wax Go to last post
82 90,662
Ryan Dnb
03-04-2016 06:13
by elementality0x Go to last post
9 3,135
Attimo
31-03-2016 13:32
by Attimo Go to last post
2 266
Palma
23-03-2016 12:48
by Palma Go to last post
0 334
mop93
19-03-2016 23:05
by highganja99 Go to last post
4 1,616


[top]References

  1. ^ Ettrup, A.; Hansen, M.; Santini, M. A.; Paine, J.; Gillings, N.; Palner, M.; Lehel, S.; Herth, M. M. et al. (2010). "Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers". European Journal of Nuclear Medicine and Molecular Imaging
  2. ^ Ralf Heim PhD. Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts. (German)


Contributors: Alfa, Docta, NeuroChi
Created by NeuroChi, 01-06-2011 at 04:48
Last edited by Docta, 15-09-2011 at 05:57
Last comment by Docta on 12-09-2011 at 06:39
1 Comments, 75,259 Views

Share this on:
Page Tools


Posting Rules
You may not create new articles
You may not edit articles
You may not protect articles

You may not post comments
You may not post attachments
You may not edit your comments

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Sitelinks: Information:

All times are GMT +1. The time now is 05:57.


Copyright: SIN Foundation 2003 - 2014, All rights reserved